Robert A Mckay

US Patent:

8171876, May 8, 2012

Filed:

Apr 28, 2008

Appl. No.:

12/149133

Inventors:

Takumi Namekawa - Chigasaki, JP
Kei Baba - Chigasaki, JP
Yuya Inoue - Chigasaki, JP
Masao Murata - Chigasaki, JP
Koji Hane - Chigasaki, JP
Robert D. Taff - Pleasanton CA, US
Robert R. McKay - Pleasanton CA, US
Ralph D. Fox - Pleasanton CA, US

Assignee:

Ulvac, Inc. - Chigasaki-shi

International Classification:

B05C 5/02

US Classification:

118300, 118600, 118602, 118603, 118610, 222318, 137563, 137206, 137209, 347 84, 347 85, 347 89

Abstract:

The present invention provides applicators reducing generating bubble. Dispersion liquid is supplied while the pressure of a circulation tank on the delivery side is lower than the atmospheric pressure but higher than the pressure of the space in buffer tanks. The dispersion liquid in the discharge chambers is recovered while the pressure in a circulation tank serving as recovery destination is lower than the atmospheric pressure. Gas dissolution can be reduced because the dispersion liquid does not come into contact with gases at pressures higher than the atmospheric pressure and engulffing gas or deformation of solid microparticles can be avoided because no pump is used.

US Patent:

20020055479, May 9, 2002

Filed:

May 14, 2001

Appl. No.:

09/854883

Inventors:

Lex Cowsert - San Mateo CA, US
Jacqueline Wyatt - Encinitas CA, US
Susan Freier - San Diego CA, US
Brett Monia - La Costa CA, US
Madeline Butler - Rancho Santa Fe CA, US
Robert McKay - San Diego CA, US

International Classification:

C07H021/04
A61K048/00

US Classification:

514/044000, 536/023200

Abstract:

Compounds, compositions and methods are provided for modulating the expression of PTP1B. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding PTP1B. Methods of using these compounds for modulation of PTP1B expression and for treatment of diseases associated with expression of PTP1B are provided.